Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer
Details
Publication Year 2021-02-26,Volume 7,Issue #9,Page eabe3348
Journal Title
Science Advances
Publication Type
Research article
Abstract
CD4 T cells have been implicated in cancer immunity for their helper functions. Moreover, their direct cytotoxic potential has been shown in some patients with cancer. Here, by mining single-cell RNA-seq datasets, we identified CD4 T cell clusters displaying cytotoxic phenotypes in different human cancers, resembling CD8 T cell profiles. Using the peptide-MHCII-multimer technology, we confirmed ex vivo the presence of cytolytic tumor-specific CD4 T cells. We performed an integrated phenotypic and functional characterization of these cells, down to the single-cell level, through a high-throughput nanobiochip consisting of massive arrays of picowells and machine learning. We demonstrated a direct, contact-, and granzyme-dependent cytotoxic activity against tumors, with delayed kinetics compared to classical cytotoxic lymphocytes. Last, we found that this cytotoxic activity was in part dependent on SLAMF7. Agonistic engagement of SLAMF7 enhanced cytotoxicity of tumor-specific CD4 T cells, suggesting that targeting these cells might prove synergistic with other cancer immunotherapies.
Keywords
*CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cytotoxicity, Immunologic; Humans; Immunotherapy; *Neoplasms; T-Lymphocytes, Cytotoxic
Department(s)
Laboratory Research
PubMed ID
33637530
Open Access at Publisher's Site
https://doi.org/10.1126/sciadv.abe3348
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2025-06-20 03:31:51
Last Modified: 2025-06-20 03:33:48

© 2025 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙